JP7437783B2 - Rice blast control agent - Google Patents
Rice blast control agent Download PDFInfo
- Publication number
- JP7437783B2 JP7437783B2 JP2021507225A JP2021507225A JP7437783B2 JP 7437783 B2 JP7437783 B2 JP 7437783B2 JP 2021507225 A JP2021507225 A JP 2021507225A JP 2021507225 A JP2021507225 A JP 2021507225A JP 7437783 B2 JP7437783 B2 JP 7437783B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- unsubstituted
- substituted
- formula
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000007164 Oryza sativa Nutrition 0.000 title claims description 47
- 235000009566 rice Nutrition 0.000 title claims description 47
- 240000007594 Oryza sativa Species 0.000 title 1
- 150000001875 compounds Chemical group 0.000 claims description 85
- 241000209094 Oryza Species 0.000 claims description 53
- -1 methoxymethoxy group Chemical group 0.000 claims description 48
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 29
- 241001330975 Magnaporthe oryzae Species 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 24
- 239000003795 chemical substances by application Substances 0.000 claims description 23
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 22
- 230000008099 melanin synthesis Effects 0.000 claims description 19
- 230000002401 inhibitory effect Effects 0.000 claims description 18
- 239000003112 inhibitor Substances 0.000 claims description 15
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 230000037361 pathway Effects 0.000 claims description 13
- 125000004432 carbon atom Chemical group C* 0.000 claims description 12
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims description 9
- 125000000623 heterocyclic group Chemical group 0.000 claims description 9
- 125000001424 substituent group Chemical group 0.000 claims description 9
- 125000005843 halogen group Chemical group 0.000 claims description 7
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 7
- 150000001413 amino acids Chemical class 0.000 claims description 6
- 229940123274 Dehydratase inhibitor Drugs 0.000 claims description 5
- 102000004867 Hydro-Lyases Human genes 0.000 claims description 5
- 108090001042 Hydro-Lyases Proteins 0.000 claims description 5
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 5
- 239000004095 hydrolyase inhibitor Substances 0.000 claims description 5
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 5
- 239000002689 soil Substances 0.000 claims description 4
- 125000000027 (C1-C10) alkoxy group Chemical group 0.000 claims description 3
- 108010030975 Polyketide Synthases Proteins 0.000 claims description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
- 230000012010 growth Effects 0.000 claims description 3
- 238000004381 surface treatment Methods 0.000 claims description 3
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 2
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims description 2
- 108010050493 polyketide synthase ketoreductase Proteins 0.000 claims description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 2
- 125000005809 3,4,5-trimethoxyphenyl group Chemical group [H]C1=C(OC([H])([H])[H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 claims 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 34
- 239000000243 solution Substances 0.000 description 34
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 16
- 239000003814 drug Substances 0.000 description 14
- 229940079593 drug Drugs 0.000 description 14
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 10
- 150000002430 hydrocarbons Chemical group 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 238000005481 NMR spectroscopy Methods 0.000 description 9
- RXDMAYSSBPYBFW-PKFCDNJMSA-N carpropamide Chemical compound N([C@@H](C)C=1C=CC(Cl)=CC=1)C(=O)[C@@]1(CC)[C@H](C)C1(Cl)Cl RXDMAYSSBPYBFW-PKFCDNJMSA-N 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 8
- 241000233866 Fungi Species 0.000 description 7
- 235000019439 ethyl acetate Nutrition 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 230000000361 pesticidal effect Effects 0.000 description 6
- 102200011314 rs782290433 Human genes 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- 125000001309 chloro group Chemical group Cl* 0.000 description 5
- 229910052740 iodine Inorganic materials 0.000 description 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- 239000001965 potato dextrose agar Substances 0.000 description 5
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 125000002252 acyl group Chemical group 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 4
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 229960000956 coumarin Drugs 0.000 description 4
- 235000001671 coumarin Nutrition 0.000 description 4
- 125000004093 cyano group Chemical group *C#N 0.000 description 4
- 229910052731 fluorine Inorganic materials 0.000 description 4
- 125000001153 fluoro group Chemical group F* 0.000 description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 238000010898 silica gel chromatography Methods 0.000 description 4
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 description 3
- BPXKZEMBEZGUAH-UHFFFAOYSA-N 2-(chloromethoxy)ethyl-trimethylsilane Chemical compound C[Si](C)(C)CCOCCl BPXKZEMBEZGUAH-UHFFFAOYSA-N 0.000 description 3
- DGMOBVGABMBZSB-UHFFFAOYSA-N 2-methylpropanoyl chloride Chemical compound CC(C)C(Cl)=O DGMOBVGABMBZSB-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 125000004423 acyloxy group Chemical group 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 239000012230 colorless oil Substances 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 125000002510 isobutoxy group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])O* 0.000 description 3
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 3
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- CHZCERSEMVWNHL-UHFFFAOYSA-N 2-hydroxybenzonitrile Chemical compound OC1=CC=CC=C1C#N CHZCERSEMVWNHL-UHFFFAOYSA-N 0.000 description 2
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 101150033646 SDH1 gene Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- 125000002102 aryl alkyloxo group Chemical group 0.000 description 2
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 2
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 150000004775 coumarins Chemical class 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000002391 heterocyclic compounds Chemical class 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000005921 isopentoxy group Chemical group 0.000 description 2
- HJOVHMDZYOCNQW-UHFFFAOYSA-N isophorone Chemical compound CC1=CC(=O)CC(C)(C)C1 HJOVHMDZYOCNQW-UHFFFAOYSA-N 0.000 description 2
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 125000004115 pentoxy group Chemical group [*]OC([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 2
- 125000005920 sec-butoxy group Chemical group 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 125000003944 tolyl group Chemical group 0.000 description 2
- 239000004563 wettable powder Substances 0.000 description 2
- CXNPLSGKWMLZPZ-GIFSMMMISA-N (2r,3r,6s)-3-[[(3s)-3-amino-5-[carbamimidoyl(methyl)amino]pentanoyl]amino]-6-(4-amino-2-oxopyrimidin-1-yl)-3,6-dihydro-2h-pyran-2-carboxylic acid Chemical compound O1[C@@H](C(O)=O)[C@H](NC(=O)C[C@@H](N)CCN(C)C(N)=N)C=C[C@H]1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-GIFSMMMISA-N 0.000 description 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 1
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 1
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 description 1
- FNQJDLTXOVEEFB-UHFFFAOYSA-N 1,2,3-benzothiadiazole Chemical compound C1=CC=C2SN=NC2=C1 FNQJDLTXOVEEFB-UHFFFAOYSA-N 0.000 description 1
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- LOAXNQQBFLSZEK-UHFFFAOYSA-N 4-(chloromethyl)-5-hydroxy-7-methylchromen-2-one Chemical compound ClCC1=CC(=O)OC2=CC(C)=CC(O)=C21 LOAXNQQBFLSZEK-UHFFFAOYSA-N 0.000 description 1
- 125000003341 7 membered heterocyclic group Chemical group 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 150000003931 anilides Chemical class 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 125000003725 azepanyl group Chemical group 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000005874 benzothiadiazolyl group Chemical group 0.000 description 1
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical class C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- CXNPLSGKWMLZPZ-UHFFFAOYSA-N blasticidin-S Natural products O1C(C(O)=O)C(NC(=O)CC(N)CCN(C)C(N)=N)C=CC1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-UHFFFAOYSA-N 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 125000003016 chromanyl group Chemical group O1C(CCC2=CC=CC=C12)* 0.000 description 1
- 125000004230 chromenyl group Chemical group O1C(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 125000000332 coumarinyl group Chemical group O1C(=O)C(=CC2=CC=CC=C12)* 0.000 description 1
- DGJMPUGMZIKDRO-UHFFFAOYSA-N cyanoacetamide Chemical class NC(=O)CC#N DGJMPUGMZIKDRO-UHFFFAOYSA-N 0.000 description 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001352 cyclobutyloxy group Chemical group C1(CCC1)O* 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000002933 cyclohexyloxy group Chemical group C1(CCCCC1)O* 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001887 cyclopentyloxy group Chemical group C1(CCCC1)O* 0.000 description 1
- 125000000131 cyclopropyloxy group Chemical group C1(CC1)O* 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 125000005959 diazepanyl group Chemical group 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 150000004659 dithiocarbamates Chemical class 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- OHLRLMWUFVDREV-UHFFFAOYSA-N ethyl 4-chloro-3-oxobutanoate Chemical compound CCOC(=O)CC(=O)CCl OHLRLMWUFVDREV-UHFFFAOYSA-N 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000005980 hexynyl group Chemical group 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000005945 imidazopyridyl group Chemical group 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 125000005932 isopentyloxycarbonyl group Chemical group 0.000 description 1
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- UFHLMYOGRXOCSL-UHFFFAOYSA-N isoprothiolane Chemical compound CC(C)OC(=O)C(C(=O)OC(C)C)=C1SCCS1 UFHLMYOGRXOCSL-UHFFFAOYSA-N 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 150000003854 isothiazoles Chemical class 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- PVTHJAPFENJVNC-MHRBZPPQSA-N kasugamycin Chemical compound N[C@H]1C[C@H](NC(=N)C(O)=O)[C@@H](C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O PVTHJAPFENJVNC-MHRBZPPQSA-N 0.000 description 1
- 239000003350 kerosene Substances 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- BSDQITJYKQHXQR-UHFFFAOYSA-N methyl prop-2-eneperoxoate Chemical compound COOC(=O)C=C BSDQITJYKQHXQR-UHFFFAOYSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000003032 molecular docking Methods 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- OIPPWFOQEKKFEE-UHFFFAOYSA-N orcinol Chemical compound CC1=CC(O)=CC(O)=C1 OIPPWFOQEKKFEE-UHFFFAOYSA-N 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000004043 oxo group Chemical group O=* 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 125000001148 pentyloxycarbonyl group Chemical group 0.000 description 1
- 125000005981 pentynyl group Chemical group 0.000 description 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
- 239000005648 plant growth regulator Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- WHHIPMZEDGBUCC-UHFFFAOYSA-N probenazole Chemical compound C1=CC=C2C(OCC=C)=NS(=O)(=O)C2=C1 WHHIPMZEDGBUCC-UHFFFAOYSA-N 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 239000002728 pyrethroid Substances 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- XRJLAOUDSILTFT-UHFFFAOYSA-N pyroquilon Chemical compound O=C1CCC2=CC=CC3=C2N1CC3 XRJLAOUDSILTFT-UHFFFAOYSA-N 0.000 description 1
- 150000003233 pyrroles Chemical class 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 125000006413 ring segment Chemical group 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 125000005930 sec-butyloxycarbonyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- DQJCHOQLCLEDLL-UHFFFAOYSA-N tricyclazole Chemical compound CC1=CC=CC2=C1N1C=NN=C1S2 DQJCHOQLCLEDLL-UHFFFAOYSA-N 0.000 description 1
- 125000000169 tricyclic heterocycle group Chemical group 0.000 description 1
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical class [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/14—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
- A01N43/16—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
- A01N47/10—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof
- A01N47/18—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof containing a —O—CO—N< group, or a thio analogue thereof, directly attached to a heterocyclic or cycloaliphatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/99—Enzyme inactivation by chemical treatment
Description
本発明はイネいもち病防除剤及びイネいもち病の防除方法に関する。 The present invention relates to an agent for controlling rice blast disease and a method for controlling rice blast disease.
イネいもち病は水イネの重要病害である。いもち病菌はメラニンを合成して自らの細胞壁の強度を高めてイネに侵入するが、メラニン合成が阻害されると、細胞壁の強度が低下して侵入できなくなるとされている。このことから、現在上市されているイネいもち病菌用農薬は、菌内のメラニン産生経路に着目し(図1参照のこと)、メラニン産生に至る各工程に関与している特定の酵素を標的として開発されたものである。例えば、前記経路の一工程に関与しているシタロン脱水酵素(SDH1)を標的とする農薬として、バイエルから1998年にカルプロパミドが、住友化学から2000年にジクロシメットが、及び日本農薬から2001年にフェノキサニルがそれぞれ上市され、汎用された時期もあったが、2001年に耐性菌が出現し、所期の効果が得られなくなり、現在では使用されていない。 Rice blast is an important disease of water rice. The rice blast fungus synthesizes melanin to strengthen its own cell wall and invades rice plants, but if melanin synthesis is inhibited, the strength of the cell wall decreases and it is unable to invade. For this reason, pesticides for rice blast fungi currently on the market focus on the melanin production pathway within the fungus (see Figure 1), and target specific enzymes involved in each step leading to melanin production. It was developed. For example, Bayer introduced carpropamide in 1998, Sumitomo Chemical introduced diclosimet in 2000, and Nihon Nohyaku introduced phenoxanil in 2001 as pesticides that target citalone dehydratase (SDH1), which is involved in one step of the pathway. There was a time when these drugs were put on the market and used widely, but in 2001, resistant bacteria appeared and the desired effects could no longer be obtained, so they are no longer used.
これまで種々の化合物を有効成分とするイネいもち病防除剤について特許出願がされているが(例えば、特許文献1~4)、クマリン骨格を有する化合物がイネいもち病防除剤として有効であるとの報告はない。 Until now, patent applications have been filed for rice blast control agents containing various compounds as active ingredients (for example, Patent Documents 1 to 4), but it has been reported that compounds having a coumarin skeleton are effective as rice blast control agents. There are no reports.
また、N-置換-4-(3-アミノ-2-ベンゾフラニル)クマリン誘導体については、例えば、非特許文献1にN-(2-フラニルカルボニル)誘導体が記載されているが、イネいもち病については何ら言及されていない。 Regarding N-substituted-4-(3-amino-2-benzofuranyl)coumarin derivatives, for example, N-(2-furanylcarbonyl) derivatives are described in Non-Patent Document 1; is not mentioned at all.
本発明は、新規なシタロン脱水酵素阻害剤及びイネいもち病防除剤、並びにその有効成分等として有用な新規化合物を提供することを課題とする。 An object of the present invention is to provide a novel citalone dehydratase inhibitor, a novel rice blast control agent, and a novel compound useful as an active ingredient thereof.
本発明者らは、前記課題を解決するため種々検討したところ、所定の構造のクマリン誘導体類が、メラニン産生経路に関与するシタロン脱水酵素(SDH1)及び/又はそのアミノ酸変異体に対しても阻害活性を有することを見出した。この知見に基づいて、更に種々検討したところ、前記クマリン誘導体類を施用することにより、野生型イネいもち病菌及び/又はその薬剤耐性菌に対して、メラニン産生を有意に抑制し、防除し得ることを見出し、本発明を完成するに至った。 The present inventors conducted various studies to solve the above problems, and found that coumarin derivatives with a predetermined structure also inhibit citalone dehydratase (SDH1) and/or its amino acid mutants, which are involved in the melanin production pathway. It was found that it has activity. Based on this knowledge, we further conducted various studies and found that by applying the coumarin derivatives, melanin production can be significantly suppressed and controlled against wild-type rice blast fungi and/or their drug-resistant bacteria. They discovered this and completed the present invention.
すなわち、本発明の要旨は以下のとおりである。
(1)次式(I):
で示される化合物から選ばれる少なくとも1種を含有するシタロン脱水酵素阻害剤。
(2)前記式(I)中、Rが表す前記置換基が、置換又は非置換のC1-10-アルキル基、置換又は非置換のC1-10-アルコキシ基、置換又は非置換のC6-10-アリールオキシ基、置換又は非置換のC7-11-アラルキルオキシ基、ハロゲン原子、又は水酸基である前記(1)に記載のシタロン脱水酵素阻害剤。
(3)前記式(I)が次式(II):
である前記(1)又は(2)に記載のシタロン脱水酵素阻害剤。
(4)前記式(II)中の置換又は非置換のC1-5-アルコキシ基がメトキシメトキシ基、(2-メトキシエトキシ)メトキシ基、[2-(トリメチルシリル)エトキシ]メトキシ基又はベンジルオキシメトキシ基である前記(3)に記載のシタロン脱水酵素阻害剤。
(5)少なくとも1種のアミノ酸が変異した非野生型シタロン脱水酵素に対して阻害活性を有する前記(1)~(4)のいずれかに記載のシタロン脱水酵素阻害剤。
(6)前記(1)~(5)のいずれかに記載のシタロン脱水酵素阻害剤を含有するイネいもち病防除剤。
(7)イネいもち病菌のメラニン生合成経路に関与する、ポリケタイド合成酵素及び還元酵素の少なくとも1種に対して阻害活性を有する少なくとも1種の化合物を更に含有する前記(6)に記載のイネいもち病防除剤。
(8)次式(IIa):
で示される化合物(但し、R1a及びR3aが水素原子であり、R2a及びR4aがメチル基であり、Xaが-CO-であり、R5aが非置換のイソプロピル基である化合物を除く)。
(9)前記式(IIa)中の置換又は非置換のC1-3-アルコキシ基がメトキシメトキシ基、(2-メトキシエトキシ)メトキシ基、[2-(トリメチルシリル)エトキシ]メトキシ基又はベンジルオキシメトキシ基である前記(8)に記載の化合物。
(10)前記(6)又は(7)に記載のイネいもち病防除剤を、イネの植物体自体、その種子、それが生育している又は生育が予定される圃場、又はその生育に利用される器具に施用する工程を含む、イネいもち病の防除方法。
(11)前記(6)又は(7)に記載のイネいもち病防除剤をイネ茎葉へ散布し、又は前記イネいもち病防除剤によるイネ経根処理、田面処理、水面処理、側条処理、土壌処理、イネ種子処理又は苗箱処理に付す工程を含む前記(10)に記載の方法。
That is, the gist of the present invention is as follows.
(1) The following formula (I):
A citalone dehydrase inhibitor containing at least one compound selected from the compounds shown below.
(2) In the formula (I), the substituent represented by R is a substituted or unsubstituted C 1-10 -alkyl group, a substituted or unsubstituted C 1-10 -alkoxy group, a substituted or unsubstituted C The citalone dehydrase inhibitor according to (1) above, which is a 6-10 -aryloxy group, a substituted or unsubstituted C 7-11 -aralkyloxy group, a halogen atom, or a hydroxyl group.
(3) The above formula (I) is the following formula (II):
The citalone dehydrase inhibitor according to (1) or (2) above.
(4) The substituted or unsubstituted C 1-5 -alkoxy group in formula (II) is a methoxymethoxy group, (2-methoxyethoxy)methoxy group, [2-(trimethylsilyl)ethoxy]methoxy group or benzyloxymethoxy group The citalone dehydrase inhibitor according to (3) above, which is
(5) The citalone dehydrase inhibitor according to any one of (1) to (4) above, which has an inhibitory activity against a non-wild type citalone dehydratase in which at least one amino acid is mutated.
(6) A rice blast control agent containing the citalone dehydratase inhibitor according to any one of (1) to (5) above.
(7) The rice blast according to (6) above, further comprising at least one compound having an inhibitory activity against at least one of polyketide synthase and reductase, which are involved in the melanin biosynthesis pathway of the rice blast fungus. Disease control agent.
(8) The following formula (IIa):
(However, a compound in which R 1a and R 3a are hydrogen atoms, R 2a and R 4a are methyl groups, X a is -CO-, and R 5a is an unsubstituted isopropyl group) except).
(9) The substituted or unsubstituted C 1-3 -alkoxy group in formula (IIa) is a methoxymethoxy group, (2-methoxyethoxy)methoxy group, [2-(trimethylsilyl)ethoxy]methoxy group or benzyloxymethoxy group The compound according to (8) above, which is a group.
(10) The rice blast control agent described in (6) or (7) above is applied to the rice plant itself, its seeds, the field where it is growing or is planned to grow, or when used for its growth. A method for controlling rice blast disease, which includes the step of applying the rice blast to a device.
(11) Spraying the rice blast control agent described in (6) or (7) above to rice stems and leaves, or treating rice with the rice blast control agent through root treatment, field surface treatment, water surface treatment, side row treatment, and soil. The method according to (10) above, including the step of subjecting the method to treatment, rice seed treatment, or seedling box treatment.
本発明によれば、新規なシタロン脱水酵素阻害剤及びイネいもち病防除剤、並びにその有効成分等として有用な新規化合物を提供することができる。 According to the present invention, it is possible to provide a novel citalone dehydratase inhibitor, a novel rice blast control agent, and a novel compound useful as an active ingredient thereof.
以下、本発明を詳細に説明する。
前記式(I)においてRで表される置換基としては、特に制限はなく、例えば、置換又は非置換の炭素数1~10の炭化水素基(例えば、アルキル基、アルケニル基、アルキニル基、シクロアルキル基、シクロアルキル-アルキル基、アラルキル基)、置換又は非置換のC1-10-アルコキシ基、置換又は非置換のC6-10-アリールオキシ基、置換又は非置換のC7-11-アラルキルオキシ基、置換又は非置換のC1-10-脂肪族アシル基、置換又は非置換の芳香族アシル基、置換又は非置換のC2-10-アルカノイルオキシ基、置換又は非置換の芳香族アシルオキシ基、アミノ基、水酸基、カルボキシル基、シアノ基、ハロゲン原子(例えば、フッ素原子、塩素原子、臭素原子、ヨウ素原子)、ニトロ基が挙げられる。
The present invention will be explained in detail below.
The substituent represented by R in the formula (I) is not particularly limited, and includes, for example, a substituted or unsubstituted hydrocarbon group having 1 to 10 carbon atoms (for example, an alkyl group, an alkenyl group, an alkynyl group, a cyclo alkyl group, cycloalkyl-alkyl group, aralkyl group), substituted or unsubstituted C 1-10 -alkoxy group, substituted or unsubstituted C 6-10 -aryloxy group, substituted or unsubstituted C 7-11 - Aralkyloxy group, substituted or unsubstituted C 1-10 -aliphatic acyl group, substituted or unsubstituted aromatic acyl group, substituted or unsubstituted C 2-10 -alkanoyloxy group, substituted or unsubstituted aromatic group Examples include an acyloxy group, an amino group, a hydroxyl group, a carboxyl group, a cyano group, a halogen atom (eg, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom), and a nitro group.
前記式(I)においてX1又はX2で表されるC1-10-アルキル基、及びRで表される置換基としてのC1-10-アルキル基としては、例えば、メチル基、エチル基、プロピル基、イソプロピル基、ブチル基、イソブチル基、sec-ブチル基、tert-ブチル基、ペンチル基、イソペンチル基、ヘキシル基、ヘプチル基、オクチル基、ノニル基、デシル基等の直鎖状又は分岐状のC1-10-アルキル基が挙げられる。 In formula (I), the C 1-10 -alkyl group represented by X 1 or X 2 and the C 1-10 -alkyl group as a substituent represented by R include, for example, a methyl group and an ethyl group. , linear or branched, such as propyl group, isopropyl group, butyl group, isobutyl group, sec-butyl group, tert-butyl group, pentyl group, isopentyl group, hexyl group, heptyl group, octyl group, nonyl group, decyl group, etc. Examples include C 1-10 -alkyl groups.
前記式(I)においてR5で表される置換又は非置換の炭素数1~10の炭化水素基としては、例えば、C1-10-アルキル基、C2-10-アルケニル基、C2-10-アルキニル基、C3-10-シクロアルキル基、C4-10-シクロアルキル-アルキル基、C7-10-アラルキル基が挙げられる。 Examples of the substituted or unsubstituted hydrocarbon group having 1 to 10 carbon atoms represented by R 5 in the formula (I) include a C 1-10 -alkyl group, a C 2-10 -alkenyl group, a C 2- Examples thereof include a 10 -alkynyl group, a C 3-10 -cycloalkyl group, a C 4-10 -cycloalkyl-alkyl group, and a C 7-10 -aralkyl group.
前記式(I)においてR5で表される置換又は非置換のヘテロ環基としては、例えば、O、S及びNから選択されるヘテロ原子を1~4個含有する飽和又は不飽和の単環3~8員、好ましくは5~7員のヘテロ環基が挙げられ、当該ヘテロ環同士、又はシクロアルキル環やベンゼン環と縮環し二から三環式ヘテロ環を形成してもよい。環原子であるS又はNが酸化されオキシドやジオキシドを形成してもよい。当該ヘテロ環は飽和ヘテロ環、芳香族ヘテロ環及びその部分的に飽和されたヘテロ環を含み、飽和ヘテロ環及び部分的に飽和されたヘテロ環においては任意の炭素原子がオキソ基で置換されていてもよい。好ましくは、ピリジル、ピラジニル、ピリミジニル、ピリダジニル、イミダゾリル、ピロリル、ピロリジル、トリアゾリル、テトラゾリル、チエニル、フリル、チアゾリル、ピラゾリル、イソチアゾリル、オキサゾリル、イソオキサゾリル、チアジアゾリル、オキサジアゾリル、キナゾリル、キノキサリニル、キノリル、イソキノリル、シンノリニル、フタラジニル、ベンゾイミダゾリル、ベンゾチアジアゾリル、ベンゾオキサゾリル、イミダゾピリジル、ベンゾフリル、ベンゾチエニル、ベンゾチアゾリル、テトラヒドロキノリル、テトラヒドロイソキノリル、ピペリジル、ピペラジニル、アゼパニル、ジアゼパニル、テトラヒドロフラニル、テトラヒドロピラニル、モルホリニル、インドリル、インダゾリル、イソインドリル、インドリニル、テトラヒドロベンゾイミダゾリル、ジヒドロベンゾイミダゾリジニル、クロメニル及びクロマニル基等が挙げられる。 The substituted or unsubstituted heterocyclic group represented by R 5 in the formula (I) is, for example, a saturated or unsaturated monocyclic ring containing 1 to 4 heteroatoms selected from O, S, and N. Examples include 3- to 8-membered, preferably 5- to 7-membered heterocyclic groups, and the heterocycles may be condensed with each other or with a cycloalkyl ring or a benzene ring to form a di- to tricyclic heterocycle. The ring atom S or N may be oxidized to form an oxide or a dioxide. The heterocycles include saturated heterocycles, aromatic heterocycles, and partially saturated heterocycles, and in the saturated heterocycles and partially saturated heterocycles, any carbon atom is substituted with an oxo group. You can. Preferably, pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, imidazolyl, pyrrolyl, pyrrolidyl, triazolyl, tetrazolyl, thienyl, furyl, thiazolyl, pyrazolyl, isothiazolyl, oxazolyl, isoxazolyl, thiadiazolyl, oxadiazolyl, quinazolyl, quinoxalinyl, quinolyl, isoquinolyl, cinnolinyl, phthalazinyl. , benzimidazolyl, benzothiadiazolyl, benzoxazolyl, imidazopyridyl, benzofuryl, benzothienyl, benzothiazolyl, tetrahydroquinolyl, tetrahydroisoquinolyl, piperidyl, piperazinyl, azepanyl, diazepanyl, tetrahydrofuranyl, tetrahydropyranyl, morpholinyl, indolyl , indazolyl, isoindolyl, indolinyl, tetrahydrobenzimidazolyl, dihydrobenzimidazolidinyl, chromenyl and chromanyl groups.
前記の炭化水素基、アルコキシ基、アリールオキシ基、アラルキルオキシ基、脂肪族アシル基、芳香族アシル基、アルカノイルオキシ基及び芳香族アシルオキシ基は、アミノ基、水酸基、カルボキシル基、シアノ基、ハロゲン原子(例えば、フッ素原子、塩素原子、臭素原子、ヨウ素原子)、ニトロ基等から選ばれる1以上の置換基で置換されていてもよい。 The above hydrocarbon groups, alkoxy groups, aryloxy groups, aralkyloxy groups, aliphatic acyl groups, aromatic acyl groups, alkanoyloxy groups and aromatic acyloxy groups include amino groups, hydroxyl groups, carboxyl groups, cyano groups, and halogen atoms. (For example, fluorine atom, chlorine atom, bromine atom, iodine atom), nitro group, etc. may be substituted with one or more substituents.
前記式(I)の一態様は、下記式(II)である。
前記式(II)中、R1及びR2のいずれか一方は、置換又は非置換のC1-5-アルキル基、又は置換又は非置換のC1-5-アルコキシ基であり、R1及びR2の他方は、水素原子、置換又は非置換のC1-5-アルキル基、又は置換又は非置換のC1-5-アルコキシ基であり;R3及びR4は、それぞれ、水素原子、水酸基、ベンジルオキシ基、C2-6-アルカノイルオキシ基、置換又は非置換のC1-5-アルキル基、又は置換又は非置換のC1-5-アルコキシ基であり;X2は前記式(I)中のX2と同義である。 In the formula (II), either one of R 1 and R 2 is a substituted or unsubstituted C 1-5 -alkyl group, or a substituted or unsubstituted C 1-5 -alkoxy group, and R 1 and The other of R 2 is a hydrogen atom, a substituted or unsubstituted C 1-5 -alkyl group, or a substituted or unsubstituted C 1-5 -alkoxy group; R 3 and R 4 are each a hydrogen atom, is a hydroxyl group, a benzyloxy group, a C 2-6 -alkanoyloxy group, a substituted or unsubstituted C 1-5 -alkyl group, or a substituted or unsubstituted C 1-5 -alkoxy group ; It has the same meaning as X 2 in I).
前記式(II)においてR1、R2、R3又はR4で表されるC1-5-アルキル基としては、メチル基、エチル基、プロピル基、イソプロピル基、ブチル基、イソブチル基、sec-ブチル基、tert-ブチル基、ペンチル基、イソペンチル基が挙げられ、これらのC1-5-アルキル基は、アミノ基、水酸基、カルボキシル基、シアノ基、ハロゲン原子(例えば、フッ素原子、塩素原子、臭素原子、ヨウ素原子)、ニトロ基等から選ばれる1以上の置換基で置換されていてもよい。 In the formula (II), the C 1-5 -alkyl group represented by R 1 , R 2 , R 3 or R 4 includes methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, sec -butyl group, tert-butyl group, pentyl group, isopentyl group, and these C 1-5 -alkyl groups include amino group, hydroxyl group, carboxyl group, cyano group, halogen atom (for example, fluorine atom, chlorine atom , bromine atom, iodine atom), nitro group, and the like.
前記式(II)においてR1、R2、R3又はR4で表されるC1-5-アルコキシ基としては、メトキシ基、エトキシ基、プロポキシ基、イソプロポキシ基、ブトキシ基、イソブトキシ基、sec-ブトキシ基、tert-ブトキシ基、ペンチルオキシ基、イソペンチルオキシ基が挙げられ、これらのC1-5-アルコキシ基は、アミノ基、水酸基、カルボキシル基、シアノ基、ハロゲン原子(例えば、フッ素原子、塩素原子、臭素原子、ヨウ素原子)、ニトロ基、C1-3-アルコキシ基(例えば、メトキシ基)、2-メトキシエトキシ基、ベンジルオキシ基、トリ(C1-3-アルキル)シリル-C1-3-アルコキシ基(例えば、2-(トリメチルシリル)エトキシ基)等から選ばれる1以上の置換基で置換されていてもよい。 In the formula (II), the C 1-5 -alkoxy group represented by R 1 , R 2 , R 3 or R 4 includes a methoxy group, an ethoxy group, a propoxy group, an isopropoxy group, a butoxy group, an isobutoxy group, Examples include sec-butoxy group, tert-butoxy group, pentyloxy group, and isopentyloxy group, and these C 1-5 -alkoxy groups include amino group, hydroxyl group, carboxyl group, cyano group, halogen atom (e.g. atom, chlorine atom, bromine atom, iodine atom), nitro group, C 1-3 -alkoxy group (e.g. methoxy group), 2-methoxyethoxy group, benzyloxy group, tri(C 1-3 -alkyl)silyl- It may be substituted with one or more substituents selected from C 1-3 -alkoxy groups (eg, 2-(trimethylsilyl)ethoxy groups) and the like.
前記式(II)においてR3又はR4で表されるC2-6-アルカノイルオキシ基としては、例えばアセトキシ基が挙げられる。 Examples of the C 2-6 -alkanoyloxy group represented by R 3 or R 4 in the formula (II) include an acetoxy group.
前記式(II)においてX2で表される-CO-R5、-CO-OR5又は-SO2-R5の置換基中、R5で表される炭素数1~10の炭化水素基としては、例えば、メチル基、エチル基、プロピル基、イソプロピル基、ブチル基、イソブチル基、sec-ブチル基、tert-ブチル基、ペンチル基、イソペンチル基、ヘキシル基、ヘプチル基、オクチル基、ノニル基、デシル基等の直鎖状又は分岐状のC1-10-アルキル基;シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基、シクロヘプチル基等のC3-10-シクロアルキル基;ビニル基、1-プロペニル基、アリル基、1-ブテニル基、2-ブテニル基、ペンテニル基、ヘキセニル基等のC2-10-アルケニル基;エチニル基、1-プロピニル基、2-プロピニル(プロパルギル)基、3-ブチニル基、ペンチニル基、ヘキシニル基等のC2-10-アルキニル基;ベンジル基、フェネチル基等のアラルキル基;フェニル基、トリル基、ナフチル基等の芳香族炭化水素基が挙げられる。 In the substituents of -CO-R 5 , -CO-OR 5 or -SO 2 -R 5 represented by X 2 in the above formula (II), a hydrocarbon group having 1 to 10 carbon atoms represented by R 5 Examples include methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, sec-butyl group, tert-butyl group, pentyl group, isopentyl group, hexyl group, heptyl group, octyl group, nonyl group. , a linear or branched C 1-10 -alkyl group such as a decyl group; a C 3-10 -cycloalkyl group such as a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group; a vinyl group, C 2-10 -alkenyl groups such as 1-propenyl group, allyl group, 1-butenyl group, 2-butenyl group, pentenyl group, hexenyl group; ethynyl group, 1-propynyl group, 2-propynyl (propargyl) group, 3 Examples include C 2-10 -alkynyl groups such as -butynyl, pentynyl and hexynyl groups; aralkyl groups such as benzyl and phenethyl groups; and aromatic hydrocarbon groups such as phenyl, tolyl and naphthyl groups.
前記炭化水素基としては、炭素数2~10の炭化水素基が好ましく、直鎖状又は分岐状のC3-10-アルキル基、C3-10-シクロアルキル基が更に好ましい。 The hydrocarbon group is preferably a hydrocarbon group having 2 to 10 carbon atoms, and more preferably a linear or branched C 3-10 -alkyl group or C 3-10 -cycloalkyl group.
前記炭化水素基は、例えば、メトキシ基、エトキシ基、プロポキシ基、イソプロポキシ基、ブトキシ基、イソブトキシ基、sec-ブトキシ基、tert-ブトキシ基、ペンチルオキシ基、イソペンチルオキシ基、ヘキシルオキシ基、シクロプロピルオキシ基、シクロブチルオキシ基、シクロペンチルオキシ基、シクロヘキシルオキシ基等のC1-6-アルコキシ基;メトキシカルボニル基、エトキシカルボニル基、プロポキシカルボニル基、イソプロポキシカルボニル基、ブトキシカルボニル基、イソブトキシカルボニル基、sec-ブトキシカルボニル基、tert-ブトキシカルボニル基、ペンチルオキシカルボニル基、イソペンチルオキシカルボニル基、シクロプロピルオキシカルボニル基、シクロブチルオキシカルボニル基、シクロペンチルオキシカルボニル基等のC1-6-アルコキシ-カルボニル基;水酸基;フェニル基、トリル基、ナフチル基等の芳香族炭化水素基;フッ素原子、塩素原子、臭素原子、ヨウ素原子等のハロゲン原子;ニトロ基;C1-6-アシル基、カルボキシル基、アラルキルオキシ基、C1-6-アルキルアミノ基、ジC1-6-アルキルアミノ基で置換されていてもよい。 The hydrocarbon group is, for example, a methoxy group, an ethoxy group, a propoxy group, an isopropoxy group, a butoxy group, an isobutoxy group, a sec-butoxy group, a tert-butoxy group, a pentyloxy group, an isopentyloxy group, a hexyloxy group, C 1-6 -alkoxy groups such as cyclopropyloxy group, cyclobutyloxy group, cyclopentyloxy group, cyclohexyloxy group; methoxycarbonyl group, ethoxycarbonyl group, propoxycarbonyl group, isopropoxycarbonyl group, butoxycarbonyl group, isobutoxy C 1-6 -alkoxy such as carbonyl group, sec-butoxycarbonyl group, tert-butoxycarbonyl group, pentyloxycarbonyl group, isopentyloxycarbonyl group, cyclopropyloxycarbonyl group, cyclobutyloxycarbonyl group, cyclopentyloxycarbonyl group - Carbonyl group; Hydroxyl group; Aromatic hydrocarbon groups such as phenyl group, tolyl group, naphthyl group; Halogen atoms such as fluorine atom, chlorine atom, bromine atom, iodine atom; Nitro group; C 1-6 -acyl group, carboxyl may be substituted with a group, an aralkyloxy group, a C 1-6 -alkylamino group, or a di-C 1-6 -alkylamino group.
前記式(II)で示される化合物としては、R1及びR2がメチル基で、R3及びR4が水素原子である化合物;R2及びR4がメチル基で、R1及びR3が水素原子である化合物;R2及びR3がメチル基で、R1及びR4が水素原子である化合物;R1及びR3がメチル基で、R2及びR4が水素原子である化合物;R2及びR4が[2-(トリメチルシリル)エトキシ]メトキシ基で、R1及びR3が水素原子である化合物;及びR2がメチル基で、R4が水酸基、メトキシ基、メトキシメトキシ基、(2-メトキシエトキシ)メトキシ基又は[2-(トリメチルシリル)エトキシ]メトキシ基で、R1及びR3が水素原子である化合物が好ましい。これらの化合物のうち、X2が-CO-R5で、R5がイソプロピル基、ブチル基、tert-ブチル基又はシクロヘキシル基である化合物が更に好ましい。 The compound represented by the formula (II) is a compound in which R 1 and R 2 are methyl groups, and R 3 and R 4 are hydrogen atoms; R 2 and R 4 are methyl groups, and R 1 and R 3 are Compounds where R 2 and R 3 are methyl groups and R 1 and R 4 are hydrogen atoms; Compounds where R 1 and R 3 are methyl groups and R 2 and R 4 are hydrogen atoms; A compound in which R 2 and R 4 are [2-(trimethylsilyl)ethoxy]methoxy groups, and R 1 and R 3 are hydrogen atoms; and R 2 is a methyl group, and R 4 is a hydroxyl group, a methoxy group, a methoxymethoxy group, Compounds in which R 1 and R 3 are hydrogen atoms in a (2-methoxyethoxy)methoxy group or a [2-(trimethylsilyl)ethoxy]methoxy group are preferred. Among these compounds, compounds in which X 2 is -CO-R 5 and R 5 is an isopropyl group, a butyl group, a tert-butyl group, or a cyclohexyl group are more preferred.
前記式(II)で示される化合物のうち、次式(IIa):
で示される化合物(但し、R1a及びR3aが水素原子であり、R2a及びR4aがメチル基であり、Xaが-CO-であり、R5aが非置換のイソプロピル基である化合物を除く)は新規化合物である。
Among the compounds represented by the formula (II), the following formula (IIa):
(However, a compound in which R 1a and R 3a are hydrogen atoms, R 2a and R 4a are methyl groups, X a is -CO-, and R 5a is an unsubstituted isopropyl group) ) are new compounds.
前記式(I)で示される化合物は、例えば、以下のようにして製造することができる。
なお、以下においては、前記式(II)において、R1及びR3が水素原子、R2がメチル基、R4が[2-(トリメチルシリル)エトキシ]メトキシ基、X2が-COCH(CH3)2である化合物を例にとり説明するが、その他の化合物も以下の方法に準じて製造することができる。
The compound represented by the formula (I) can be produced, for example, as follows.
In the following, in the formula (II), R 1 and R 3 are hydrogen atoms, R 2 is a methyl group, R 4 is a [2-(trimethylsilyl)ethoxy]methoxy group, and X 2 is -COCH(CH 3 ) Compound 2 will be explained as an example, but other compounds can also be produced according to the following method.
クマリン化合物dのケトン系有機溶媒(例えば、2-ブタノン)溶液に2-シアノフェノールと塩基(例えば、炭酸カリウム)を加え、加熱下反応させて、化合物fを得る。次いで、化合物fの無水有機溶媒(例えば、無水ジクロロメタン)溶液に塩基(トリエチルアミン)とイソブチリルクロライドを加えて、不活性ガス雰囲気下反応させることにより、化合物26を得ることができる。 2-cyanophenol and a base (eg, potassium carbonate) are added to a solution of coumarin compound d in a ketone organic solvent (eg, 2-butanone) and reacted under heating to obtain compound f. Next, compound 26 can be obtained by adding a base (triethylamine) and isobutyryl chloride to a solution of compound f in an anhydrous organic solvent (for example, anhydrous dichloromethane) and allowing the reaction to occur under an inert gas atmosphere.
前記のようにして得られる生成物を精製するには、通常用いられる手法、例えばシリカゲル等を担体として用いたカラムクロマトグラフィーやメタノール、エタノール、クロロホルム、ジメチルスルホキシド、水等を用いた再結晶法によればよい。カラムクロマトグラフィーの溶出溶媒としては、メタノール、エタノール、クロロホルム、アセトン、ヘキサン、ジクロロメタン、酢酸エチル、及びこれらの混合溶媒等が挙げられる。 To purify the product obtained as described above, a commonly used method such as column chromatography using silica gel as a carrier or recrystallization method using methanol, ethanol, chloroform, dimethyl sulfoxide, water, etc. All you have to do is follow. Examples of elution solvents for column chromatography include methanol, ethanol, chloroform, acetone, hexane, dichloromethane, ethyl acetate, and mixed solvents thereof.
また、前記式(I)で示される化合物のうち、市販されているものは、これらの市販品を本発明に用いることができる。 Furthermore, among the compounds represented by the formula (I), commercially available products can be used in the present invention.
本発明のシタロン脱水酵素(SDH1)阻害剤は、その活性成分として前記式(I)の化合物の少なくとも1種を含有する。前記式(I)の化合物は、イネいもち病菌のメラニン産生経路に関与するSDH1及び/又はそのアミノ酸変異体(V75M変異体)に対して阻害活性を有する。イネいもち病薬剤耐性菌は、SDH1のV75M変異により薬剤耐性を示すとされている。よって、本発明のSDH1阻害剤は、イネいもち病の薬剤耐性菌に対しても効果を奏する。より具体的には、前記式(I)の化合物を含む本発明の防除剤をイネいもち病菌ないしその薬剤耐性菌に施用すると、イネいもち病菌のメラニン産生能が抑制され、その結果、イネいもち病菌の植物細胞への侵入を防除できる。前記式(I)の化合物の中には、SDH1及びそのV75変異体の双方に対して阻害活性を有する化合物、又はV75変異体のみに高い阻害活性を示す化合物もある。この作用機序については、詳細は明らかではないが、ドッキングシミュレーションの結果は、前記式(I)の化合物が、既存のSDH1阻害性イネいもち病菌防除剤であるカルプロパミドと同様、SDH1に結合することで活性を阻害していること、但し、その結合様式がカルプロパミドとは異なるであろう、ことを示唆した。この性質は、前記式(I)で示される共通の構造に基づくものと推察される。 The cytalone dehydratase (SDH1) inhibitor of the present invention contains at least one compound of formula (I) as its active ingredient. The compound of formula (I) has inhibitory activity against SDH1 and/or its amino acid variant (V75M variant), which is involved in the melanin production pathway of the rice blast fungus. Rice blast drug-resistant bacteria are said to exhibit drug resistance due to the V75M mutation in SDH1. Therefore, the SDH1 inhibitor of the present invention is also effective against drug-resistant bacteria of rice blast. More specifically, when the pesticidal agent of the present invention containing the compound of formula (I) is applied to rice blast fungi or its drug-resistant bacteria, the melanin production ability of rice blast fungi is suppressed, and as a result, the rice blast fungus is inhibited. can prevent invasion of plant cells. Among the compounds of formula (I), there are also compounds that have inhibitory activity against both SDH1 and its V75 mutant, or compounds that exhibit high inhibitory activity only against the V75 mutant. Although the details of this mechanism of action are not clear, the results of docking simulations indicate that the compound of formula (I) binds to SDH1 in the same manner as carpropamide, an existing SDH1-inhibiting rice blast control agent. However, it was suggested that the binding mode may be different from that of carpropamide. This property is presumed to be based on the common structure shown by the above formula (I).
本発明の防除剤は、担体を用い、更に必要に応じて適切な補助剤を配合して、適切な剤形とされて提供されることが好ましい。例えば油剤、乳剤、粉剤、水和剤、粒剤、懸濁剤等に製剤し、適宜希釈するなどして使用するのが好ましい。 It is preferable that the pesticidal agent of the present invention is provided in an appropriate dosage form using a carrier and, if necessary, adding an appropriate adjuvant. For example, it is preferable to formulate it into an oil, emulsion, powder, wettable powder, granule, suspension, etc., and dilute it appropriately before use.
好ましく用いられる担体としては、クレー、タルク、珪藻土、白土、炭酸カルシウム、無水珪酸、ベントナイト、硫酸ナトリウム、シリカゲル、有機酸塩類、糖類、澱粉、樹脂類、合成もしくは天然高分子等の固体粉末あるいは粒状担体、キシレン等の芳香族炭化水素類、ケロシン等の脂肪族炭化水素類、メチルエチルケトン、シクロヘキサノン、イソホロン等のケトン類、ラクタム類、アニソール等のエーテル類、エタノール、プロパノール、エチレングリコール等のアルコール類、酢酸エチル、酢酸ブチル等のエステル類、ジメチルスルホキシド、ジメチルホルムアミド、水等の液体担体が挙げられる。 Preferably used carriers include solid powders or granules of clay, talc, diatomaceous earth, clay, calcium carbonate, silicic anhydride, bentonite, sodium sulfate, silica gel, organic acid salts, sugars, starches, resins, synthetic or natural polymers, etc. Carriers, aromatic hydrocarbons such as xylene, aliphatic hydrocarbons such as kerosene, ketones such as methyl ethyl ketone, cyclohexanone, isophorone, lactams, ethers such as anisole, alcohols such as ethanol, propanol, ethylene glycol, etc. Examples include esters such as ethyl acetate and butyl acetate, and liquid carriers such as dimethyl sulfoxide, dimethylformamide, and water.
更に、防除剤の効果をより確実にするために、乳化剤、分散剤、湿潤剤、結合剤、滑沢剤等の補助剤を目的に応じて適宜選択し、組み合わせるなどして用いることが望ましい。そのような補助剤の例としては例えば非イオン性又はイオン性の界面活性剤、カルボキシメチルセルロース、ポリ酢酸ビニル、ポリビニルアルコール、ガム類、ステアリン酸塩類、ワックス、糊料等が挙げられる。 Furthermore, in order to ensure the effectiveness of the pesticidal agent, it is desirable to appropriately select and combine auxiliary agents such as emulsifiers, dispersants, wetting agents, binders, and lubricants depending on the purpose. Examples of such adjuvants include nonionic or ionic surfactants, carboxymethylcellulose, polyvinyl acetate, polyvinyl alcohol, gums, stearates, waxes, thickeners, and the like.
本発明の防除剤においては、前記式(I)の化合物を、通常、粉剤の場合には0.01~10質量%程度、好ましくは0.1~5質量%程度、水和剤の場合には1~90質量%程度、好ましくは5~75質量%程度、粒剤の場合には0.01~40質量%程度、好ましくは0.1~20質量%程度、液剤の場合には1~60質量%程度、好ましくは5~40質量%程度、懸濁剤の場合には1~80質量%程度、好ましくは5~50質量%程度含有させる。 In the pesticidal agent of the present invention, the compound of the formula (I) is usually about 0.01 to 10% by mass in the case of a powder, preferably about 0.1 to 5% by mass in the case of a wettable powder. is about 1 to 90% by mass, preferably about 5 to 75% by mass, about 0.01 to 40% by mass in the case of granules, preferably about 0.1 to 20% by mass, and about 1 to 20% by mass in the case of liquids. The content is about 60% by mass, preferably about 5 to 40% by mass, and in the case of a suspending agent, about 1 to 80% by mass, preferably about 5 to 50% by mass.
本発明のイネいもち病防除剤は、単独で使用できることはもちろんであるが、ブラストサイジンS、カスガマイシン、トリサイクラゾール、ピロキロン、イソプロチオラン、フサライド、プロベナゾール、メトキシアクリレート系、ベンズチアジアゾール系、シクロプロパン系、ピリミジン系、ジチオカーバメート系、カーバメート系、ベンズイミダゾール系、ベンズチアゾール系、トリアジン系、シアノ酢酸アミド系、イミダゾール系、ピロール系、ニコチノイド系、グアニジン系、ニトロメチレン系、シアノメチレン系、イソチアゾール系、アニライド系、キノリン系、有機塩素系、スルホン酸アミド系、ピレスロイド系、スルホニル尿素系、尿素系、有機リン系化合物等の殺菌剤、殺虫剤、除草剤、植物成長調節剤、あるいは肥料等と併用して、若しくは混合剤として使用することもできる。 The rice blast control agent of the present invention can of course be used alone, but it also includes blasticidin S, kasugamycin, tricyclazole, pyroquilon, isoprothiolane, fusaride, probenazole, methoxyacrylate type, benzthiadiazole type, and cyclopropane type. , pyrimidine series, dithiocarbamate series, carbamate series, benzimidazole series, benzthiazole series, triazine series, cyanoacetamide series, imidazole series, pyrrole series, nicotinoid series, guanidine series, nitromethylene series, cyanomethylene series, isothiazole series , anilide-based, quinoline-based, organochlorine-based, sulfonamide-based, pyrethroid-based, sulfonylurea-based, urea-based, organophosphorus-based compounds and other fungicides, insecticides, herbicides, plant growth regulators, or fertilizers. They can also be used in combination or as a mixture.
また、本発明の防除剤は、前記式(I)で示される化合物の少なくとも1種とともにメラニン産生経路に関与する他の酵素に対する阻害剤の少なくとも1種、具体的には、ポリケタイド合成酵素及び還元酵素の少なくとも1種に対して阻害活性を有する少なくとも1種の化合物を更に含有していてもよい。施用する土壌等の生存菌の分布や、植物種に応じて、最適な割合で配合することができる。 In addition, the pesticidal agent of the present invention includes at least one of the compounds represented by the formula (I) and at least one inhibitor of other enzymes involved in the melanin production pathway, specifically, polyketide synthase and It may further contain at least one compound having inhibitory activity against at least one enzyme. It can be blended in an optimal ratio depending on the distribution of viable bacteria in the soil etc. to which it is applied and the plant species.
本発明のイネいもち病の防除方法は、前記式(I)で示される化合物を、イネの植物体自体、その種子、それが生育している又は生育を予定される圃場、又はその生育に利用される器具に施用する工程を含んでなるものである。より具体的には、イネいもち病の発生が予想される場合に、予め前記式(I)の化合物をイネ茎葉への散布するほか、イネの経根、田面、水面、側条、土壌、種子、苗箱などに前記式(I)の化合物を施用する。あるいは、イネいもち病菌に感染した結果、病害が発生、蔓延した後に、前記のように前記式(I)の化合物を使用することにより、病害を除きあるいは抑制することができる。 The method for controlling rice blast of the present invention uses the compound represented by the formula (I) on the rice plant itself, its seeds, the field where it is growing or planned to grow, or its growth. The method includes a step of applying the method to a device to be used. More specifically, when the outbreak of rice blast disease is expected, the compound of the formula (I) is sprayed in advance on the rice stems and leaves, as well as on the rice roots, field surface, water surface, lateral stripes, soil, and seeds. , the compound of formula (I) is applied to seedling boxes and the like. Alternatively, after the disease has occurred and spread as a result of infection with the rice blast fungus, the disease can be eliminated or suppressed by using the compound of formula (I) as described above.
本発明の防除剤の適用量は、製剤の形態及び施用する方法、目的、時期を考慮して適宜決定されるが、通常、有効成分である前記式(I)の化合物の量に換算して、1ha当たり10~2000gの範囲で適用するのが好ましく、より好ましくは50~1000gの範囲である。 The amount of the pesticidal agent of the present invention to be applied is appropriately determined taking into account the form of the preparation and the method, purpose, and timing of application, but is usually calculated in terms of the amount of the compound of formula (I), which is the active ingredient. It is preferably applied in an amount of 10 to 2,000 g per ha, more preferably in a range of 50 to 1,000 g.
本明細書は、本願の優先権の基礎である特願2019-048574の明細書及び/又は図面に記載される内容を包含する。 This specification includes the contents described in the specification and/or drawings of Japanese Patent Application No. 2019-048574, which is the basis of the priority of this application.
以下、実施例を挙げて本発明を更に具体的に説明するが、本発明の範囲は以下の実施例に限定されるものではない。 EXAMPLES Hereinafter, the present invention will be described in more detail with reference to Examples, but the scope of the present invention is not limited to the following Examples.
合成に用いた溶媒は、いずれも試薬グレードのものである。無水ジクロロメタン(CH2Cl2)は、和光純薬から入手した。 All solvents used in the synthesis were of reagent grade. Anhydrous dichloromethane (CH 2 Cl 2 ) was obtained from Wako Pure Chemical.
各反応は、0.25mmプレコートされたシリカゲルプレート(Merck KGaA製)を用いた薄層クロマトグラフィー(TLC)によってモニターした。 Each reaction was monitored by thin layer chromatography (TLC) using 0.25 mm precoated silica gel plates (Merck KGaA).
関東化学のシリカゲル60N(球状;中性;0.04-0.05mm)をフラッシュクロマトグラフィーに用いた。 Silica gel 60N (spherical; neutral; 0.04-0.05 mm) manufactured by Kanto Kagaku was used for flash chromatography.
1H NMR は、JEOL JNM-ECA-500 (500 MHz) スペクトロメータを用いて、内部標準としてのテトラメチルシラン(0ppm)を含むCDCl3中で、又は溶媒及び内部標準(3.30ppm)としてのCD3OD中で測定した。各略記、Sはシングレット、dはダブレット、tはトリプレット、qはクオーテット、mはマルチプレット、brはブロードを意味する。 1 H NMR was performed using a JEOL JNM-ECA-500 (500 MHz) spectrometer in CDCl 3 with tetramethylsilane (0 ppm) as an internal standard or in CDCl 3 as a solvent and an internal standard (3.30 ppm). Measured in CD3OD . In each abbreviation, S means singlet, d means doublet, t means triplet, q means quartet, m means multiplet, and br means broad.
13C NMRは、JEOL JNM-ECA-500 (125 MHz)スペクトロメータを用いて、溶媒及び内部標準(それぞれ、77.0又は49.0ppmである)としてCDCl3又はCD3OD中で測定した。 13 C NMR was measured in CDCl 3 or CD 3 OD as solvent and internal standard (77.0 or 49.0 ppm, respectively) using a JEOL JNM-ECA-500 (125 MHz) spectrometer.
実施例1:化合物26の合成例
以下の工程1~4により、化合物26を合成した。
Example 1: Synthesis example of compound 26 Compound 26 was synthesized by the following steps 1 to 4.
工程1:4-(クロロメチル)-5-ヒドロキシ-7-メチル-2H-クロメン-2-オン(化合物c)の合成
4-クロロ-3-オキソブタン酸エチル(a)(2.47g,15mmol)と5-メチルベンゼン-1,3-ジオール(b)(1.24g,10mmol)のトルエン(40mL)溶液に5滴の濃硫酸を加え、85℃で一晩加熱した。室温に冷却後、析出した固体をろ取した。固体を水、EtOAcで洗浄後乾燥し、淡黄色固体(1.23g)を得た。また、有機層を水、飽和食塩水で洗浄後、MgSO4で乾燥し、溶媒を減圧留去した。残渣を再びトルエン中濃硫酸と加熱し、淡黄色固体(0.81g)を得た。最後にその有機層を水、飽和食塩水で洗浄後MgSO4で乾燥し、溶媒を減圧留去した。残渣をシリカゲルカラムクロマトグラフィー(CHCl3:MeOH=10:1)に付し、無色の化合物c(0.05g)を得た。化合物cの全収率は93.1%であった。なお、前記工程1については、a) Xie, L.; Takeuchi, Y.; Cosentino, L. M.; McPhail, A.T.; Lee, K.-H. J. Med. Chem, 2001, 44, 664-671. b) Zak, J.; Ron, D.; Riva, E.; Harding, H. P.; Cross, B. C. S.; Baxendale, I. R. Chem. Eur. J. 2012, 18, 9901-9910に記載の方法を参照した。
化合物(c): 1H NMR (500 MHz, CD3OD) δ 2.33 (s, 3H), 5.09 (d, J = 1.0 Hz, 2H), 6.46 (brs, 1H), 6.58 (brs,, 1H), 6.68 (brs, 1H).
13C NMR (125 MHz, CD3OD) δ 21.6, 45.9, 106.1, 109.5, 112.4, 113.2, 145.4, 154.4, 156.4, 157.1, 163.1.
Add 5 drops of ethyl 4-chloro-3-oxobutanoate (a) (2.47 g, 15 mmol) and 5-methylbenzene-1,3-diol (b) (1.24 g, 10 mmol) in toluene (40 mL). Concentrated sulfuric acid was added and heated at 85°C overnight. After cooling to room temperature, the precipitated solid was collected by filtration. The solid was washed with water and EtOAc and dried to obtain a pale yellow solid (1.23 g). Further, the organic layer was washed with water and saturated brine, dried over MgSO 4 , and the solvent was distilled off under reduced pressure. The residue was heated again with concentrated sulfuric acid in toluene to give a pale yellow solid (0.81 g). Finally, the organic layer was washed with water and saturated brine, dried over MgSO 4 , and the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography (CHCl 3 :MeOH=10:1) to obtain colorless compound c (0.05 g). The overall yield of compound c was 93.1%. Regarding step 1, a) Xie, L.; Takeuchi, Y.; Cosentino, LM; McPhail, AT; Lee, K.-HJ Med. Chem, 2001, 44, 664-671. b) Zak, Reference was made to the method described in J.; Ron, D.; Riva, E.; Harding, HP; Cross, BCS; Baxendale, IR Chem. Eur. J. 2012, 18, 9901-9910.
Compound (c): 1 H NMR (500 MHz, CD 3 OD) δ 2.33 (s, 3H), 5.09 (d, J = 1.0 Hz, 2H), 6.46 (brs, 1H), 6.58 (brs,, 1H) , 6.68 (brs, 1H).
13C NMR (125 MHz, CD 3 OD) δ 21.6, 45.9, 106.1, 109.5, 112.4, 113.2, 145.4, 154.4, 156.4, 157.1, 163.1.
工程2:4-(クロロメチル)-7-メチル-5-((2-(トリメチルシリル)エトキシ)メトキシ)-2H-クロメン-2-オン(化合物d)の合成
クマリン化合物c(44.8mg,0.2mmol)と2-(トリメチルシリル)エトキシメチルクロライド(SEMCl)(42.6μL,2.4mmol)の無水CH2Cl2(5mL)溶液にジイソプロピルエチルアミン(41.8μL,2.4mmol)を加え、窒素雰囲気下室温で3時間攪拌した。混合物に水-CH2Cl2を加え希釈した。有機層を水、飽和食塩水で洗浄後、MgSO4で乾燥し、溶媒を減圧留去した。残渣をシリカゲルカラムクロマトグラフィー(n-ヘキサン:EtOAc=2:1)に付し、無色オイル(化合物d)(42.0mg,59%)を得た。なお、前記工程2については、Lipshutz, B. H.; Pegram, J. J. Tetrahedron Lett. 1980, 21, 3343-3346に記載の方法を参照した。
化合物d: 1H NMR (500 MHz, CDCl3) δ 0.02 (s, 9H), 0.99 (t, J = 8.0 Hz, 2H), 2.41 (s, 3H), 3.81 (t, J = 8.0 Hz, 2H), 4.93 (d, J = 1.5 Hz, 2H), 5.19 (s, 2H), 6.54 (brs, 1H), 6.84 (brs, 1H), 6.88 (brs, 1H).
13C NMR (125 MHz, CDCl3) δ -1.4, 18.0, 22.0, 45.4, 67.2, 93.5, 106.3, 110.8, 111.3, 114.1, 143.8, 150.6, 154.9, 155.1, 160.5.
Diisopropylethylamine (41.8 μL) was added to a solution of coumarin compound c (44.8 mg, 0.2 mmol) and 2-(trimethylsilyl)ethoxymethyl chloride (SEMCl) (42.6 μL, 2.4 mmol) in anhydrous CH 2 Cl 2 (5 mL). , 2.4 mmol) and stirred at room temperature under nitrogen atmosphere for 3 hours. The mixture was diluted with water-CH 2 Cl 2 . The organic layer was washed with water and saturated brine, dried over MgSO 4 , and the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography (n-hexane:EtOAc=2:1) to obtain a colorless oil (compound d) (42.0 mg, 59%). For step 2, reference was made to the method described in Lipshutz, BH; Pegram, JJ Tetrahedron Lett. 1980, 21, 3343-3346.
Compound d: 1 H NMR (500 MHz, CDCl 3 ) δ 0.02 (s, 9H), 0.99 (t, J = 8.0 Hz, 2H), 2.41 (s, 3H), 3.81 (t, J = 8.0 Hz, 2H ), 4.93 (d, J = 1.5 Hz, 2H), 5.19 (s, 2H), 6.54 (brs, 1H), 6.84 (brs, 1H), 6.88 (brs, 1H).
13 C NMR (125 MHz, CDCl 3 ) δ -1.4, 18.0, 22.0, 45.4, 67.2, 93.5, 106.3, 110.8, 111.3, 114.1, 143.8, 150.6, 154.9, 155.1, 160.5.
工程3:4-(3-アミノベンゾフラン-2-イル)-7-メチル-5-((2-(トリメチルシリル)エトキシ)メトキシ)-2H-クロメン-2-オン(化合物f)の合成
クマリン化合物d(420mg,1.2mmol)の2-ブタノン(20mL)溶液に2-シアノフェノール(282mg,2.4mmol)とK2CO3(652mg,4.7mmol)を加え、一晩加熱還流した。溶媒を減圧留去後、残渣を水、EtOAcで希釈した。有機層を水、飽和食塩水で洗浄後、MgSO4で乾燥し、溶媒を減圧留去した。残渣をシリカゲルカラムクロマトグラフィー(ベンゼン:アセトニトリル=10:1)に付し、無色オイル(化合物f)(251mg,49%)を得た。
化合物f: 1H NMR (500 MHz, CDCl3) δ -0.06 (s, 9H), 0.77 (t, J = 8.0 Hz, 2H), 2.42 (s, 3H), 3.49 (t, J = 8.0 Hz, 2H), 4.96 (s, 2H), 6.45 (s, 1H), 6.86 (brs, 2H), 7.27 (ddd, J = 8.0, 8.0, 2.0 Hz, 1H), 7.35 (ddd, J = 8.0, 8.0, 1.0 Hz, 1H), 7.36 (dd, J = 8.0, 2.0 Hz, 1H), 7.53 (dd, J = 8.0, 1.0 Hz, 1H).
13C NMR (125 MHz, CDCl3) δ -1.5, 17.9, 22.0, 66.7, 94.2, 106.8, 111.0, 111.3, 111.5, 113.6, 118.6, 122.1, 123.8, 125.9, 126.9, 134.1, 142.3, 144.1, 153.3, 154.9, 155.6, 160.8.
2-cyanophenol (282 mg, 2.4 mmol) and K 2 CO 3 (652 mg, 4.7 mmol) were added to a solution of coumarin compound d (420 mg, 1.2 mmol) in 2-butanone (20 mL), and the mixture was heated under reflux overnight. . After removing the solvent under reduced pressure, the residue was diluted with water and EtOAc. The organic layer was washed with water and saturated brine, dried over MgSO 4 , and the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography (benzene:acetonitrile=10:1) to obtain a colorless oil (compound f) (251 mg, 49%).
Compound f: 1 H NMR (500 MHz, CDCl 3 ) δ -0.06 (s, 9H), 0.77 (t, J = 8.0 Hz, 2H), 2.42 (s, 3H), 3.49 (t, J = 8.0 Hz, 2H), 4.96 (s, 2H), 6.45 (s, 1H), 6.86 (brs, 2H), 7.27 (ddd, J = 8.0, 8.0, 2.0 Hz, 1H), 7.35 (ddd, J = 8.0, 8.0, 1.0 Hz, 1H), 7.36 (dd, J = 8.0, 2.0 Hz, 1H), 7.53 (dd, J = 8.0, 1.0 Hz, 1H).
13 C NMR (125 MHz, CDCl 3 ) δ -1.5, 17.9, 22.0, 66.7, 94.2, 106.8, 111.0, 111.3, 111.5, 113.6, 118.6, 122.1, 123.8, 125.9, 126.9, 134. 1, 142.3, 144.1, 153.3, 154.9, 155.6, 160.8.
工程4:N-(2-(7-メチル-2-オキソ-5-((2-(トリメチルシリル)エトキシ)メトキシ)-2H-クロメン-4-イル)ベンゾフラン-3-イル)イソブチルアミド(化合物26)
クマリン化合物f(250mg,0.57mmol)の無水CH2Cl2(10mL)溶液にトリエチルアミン(159μL,1.14mmol)とイソブチリルクロライド(72μL,0.68mmol)を加えた。窒素雰囲気下室温で一晩攪拌後、混合物を水、EtOAcで希釈した。有機層を水、飽和食塩水で洗浄後、MgSO4で乾燥し、溶媒を減圧留去した。残渣をシリカゲルカラムクロマトグラフィー(n-ヘキサン:EtOAc=2:1)に付し、無色オイル(化合物26)(263mg,91%)を得た。なお、工程3及び4については、a) Karn, I. A. Kurkarni, M. V. Gopal, M.; Shahabuddin, M. S.; Sun, C.-M. Bioorg. Med. Chem. Lett. 2005, 15, 3584-3587. b) Frasinyuk, M. S.; Gorelov, S. V.; Bondarenkoo, S. P.; Khilya, V. P. Chem. Heterocyclic Compounds, 2009, 45, 1261-1269に記載の方法を参照した。
化合物26: 1H NMR (500 MHz, CDCl3) δ -0.06 (s, 9H), 0.72 (t, J = 8.0 Hz, 2H), 1.22 (d, J = 7.0 Hz, 6H), 2.40 (s, 3H), 2.58 (qq, J = 7.0, 7.0 Hz, 1H), 3.39 (t, J = 8.0 Hz, 2H), 4.87 (s, 2H), 6.37 (s, 1H), 6.80 (brs, 1H), 6.82 (brs, 1H), 7.29 (dd, J = 8.0, 8.0 Hz, 1H), 7.35 (ddd, J = 8.0, 8.0, 1.0 Hz, 1H), 7.43 (brd, J = 8.0 Hz, 1H), 7.59 (brd,J = 8.0 Hz, 1H).
13C NMR (125 MHz, CDCl3) δ -1.6, 17.7, 19.6, 22.1, 35.6, 66.7, 93.9, 106.7, 111.0, 111.3, 111.4, 116.2, 117.1, 120.8, 123.1, 125.1, 125.5, 141.7, 144.4, 144.7, 153.5, 154.4, 155.2, 160.3, 175.8.
Triethylamine (159 μL, 1.14 mmol) and isobutyryl chloride (72 μL, 0.68 mmol) were added to a solution of coumarin compound f (250 mg, 0.57 mmol) in anhydrous CH 2 Cl 2 (10 mL). After stirring overnight at room temperature under nitrogen atmosphere, the mixture was diluted with water, EtOAc. The organic layer was washed with water and saturated brine, dried over MgSO 4 , and the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography (n-hexane:EtOAc=2:1) to obtain a colorless oil (Compound 26) (263 mg, 91%). For steps 3 and 4, a) Karn, IA Kurkarni, MV Gopal, M.; Shahabuddin, MS; Sun, C.-M. Bioorg. Med. Chem. Lett. 2005, 15, 3584-3587. b ) Frasinyuk, MS; Gorelov, SV; Bondarenkoo, SP; Khilya, VP Chem. Heterocyclic Compounds, 2009, 45, 1261-1269.
Compound 26: 1 H NMR (500 MHz, CDCl 3 ) δ -0.06 (s, 9H), 0.72 (t, J = 8.0 Hz, 2H), 1.22 (d, J = 7.0 Hz, 6H), 2.40 (s, 3H), 2.58 (qq, J = 7.0, 7.0 Hz, 1H), 3.39 (t, J = 8.0 Hz, 2H), 4.87 (s, 2H), 6.37 (s, 1H), 6.80 (brs, 1H), 6.82 (brs, 1H), 7.29 (dd, J = 8.0, 8.0 Hz, 1H), 7.35 (ddd, J = 8.0, 8.0, 1.0 Hz, 1H), 7.43 (brd, J = 8.0 Hz, 1H), 7.59 (brd,J = 8.0 Hz, 1H).
13 C NMR (125 MHz, CDCl 3 ) δ -1.6, 17.7, 19.6, 22.1, 35.6, 66.7, 93.9, 106.7, 111.0, 111.3, 111.4, 116.2, 117.1, 120.8, 123.1, 125.1, 125.5, 141.7, 144.4, 144.7, 153.5, 154.4, 155.2, 160.3, 175.8.
前記合成例において、工程1に用いた試薬(化合物b)、工程2に用いた試薬SEMCl、及び工程4に用いた試薬イソブチリルクロライドの少なくとも1つを、対応する試薬にそれぞれ置き換えて、同様に反応を進行させて、化合物1~25及び27~48をそれぞれ合成した。
化合物49~59は、ナミキ商事から入手した。
化合物60~64は、理研天然化合物バンクに収載されている化合物である。
In the above synthesis example, at least one of the reagent used in step 1 (compound b), the reagent SEMCl used in step 2, and the reagent isobutyryl chloride used in step 4 was replaced with the corresponding reagent, and the same procedure was carried out. The reaction proceeded to synthesize compounds 1 to 25 and 27 to 48, respectively.
Compounds 49-59 were obtained from Namiki Shoji.
Compounds 60 to 64 are compounds listed in the RIKEN Natural Compound Bank.
実施例2:SDH1阻害活性評価
前記式(I)の各化合物について、図1中に示すメラニン生合成経路におけるSDH1に対する阻害活性を評価するために、以下の試験を行った。なお、SDH1として、野生型イネいもち病菌由来のSDH1及び薬剤耐性イネいもち病菌由来のSDH1(V75)を用いた。なお、薬剤耐性イネいもち病菌由来のSDH1は、75位のバリンがメチオニンに置換されているV75M型である。これらの酵素の調製及び阻害活性測定は文献X(Yamada, N., Motoyama, T., Nakasako, M., Kagabu, S., Kudo, T., Yamaguchi, I.: “Enzymatic characterization of scytalone dehydratase Val75Met variant found in melanin biosynthesis dehydratase inhibitor (MBI-D) resistant strains of the rice blast fungus”, Biosci. Biotechnol. Biochem. 68: 615-621 (2004))に記載の方法で行った。下記表に示す各化合物を所定の濃度(0.3nM~30μM)でそれぞれ添加し、基質であるシタロンの濃度を50μMに固定し、反応の進行を352nmの吸収の増加でモニタリングした。DMSOコントロールに対する活性(%)を求め、コントロールの活性の50%を示した時の各化合物の濃度をIC50とした。なお、比較例として、前記式(I)の化合物にかえてカルプロパミド(CPD;和光純薬から入手;既存のSDH1阻害剤)を添加した比較例用試料液についても同様に評価した。その結果、SDH1(WT型)に対する50%阻害濃度(IC50)は、3nM未満であり、SDH1(V75M型)に対するIC50は100nMであった。表中に示す結果から、前記式(I)の化合物は、SDH1に対して阻害活性を有することが理解できる。また、化合物によっては、既存の阻害剤CPDでは弱くしか阻害できないアミノ酸変異SDH1に対しても、強力な阻害活性を有することが理解できる。
Example 2: Evaluation of SDH1 inhibitory activity In order to evaluate the inhibitory activity of each compound of formula (I) against SDH1 in the melanin biosynthesis pathway shown in FIG. 1, the following test was conducted. As SDH1, SDH1 derived from wild-type rice blast fungus and SDH1 (V75) derived from drug-resistant rice blast fungus were used. Note that SDH1 derived from the drug-resistant rice blast fungus is the V75M type in which valine at position 75 is replaced with methionine. The preparation and inhibitory activity measurements of these enzymes are described in Reference The test was carried out using the method described in "variant found in melanin biosynthesis dehydratase inhibitor (MBI-D) resistant strains of the rice blast fungus", Biosci. Biotechnol. Biochem. 68: 615-621 (2004)). Each compound shown in the table below was added at a predetermined concentration (0.3 nM to 30 μM), the concentration of citalone as a substrate was fixed at 50 μM, and the progress of the reaction was monitored by the increase in absorption at 352 nm. The activity (%) relative to the DMSO control was determined, and the concentration of each compound that showed 50% of the activity of the control was defined as IC 50 . As a comparative example, a sample solution for a comparative example in which carpropamide (CPD; obtained from Wako Pure Chemical Industries, Ltd.; an existing SDH1 inhibitor) was added instead of the compound of formula (I) was evaluated in the same manner. As a result, the 50% inhibitory concentration (IC 50 ) for SDH1 (WT type) was less than 3 nM, and the IC 50 for SDH1 (V75M type) was 100 nM. From the results shown in the table, it can be seen that the compound of formula (I) has inhibitory activity against SDH1. Furthermore, it can be understood that some compounds have strong inhibitory activity against amino acid mutant SDH1, which can only be weakly inhibited by the existing inhibitor CPD.
実施例3:イネいもち病菌に対するメラニン化阻害活性のin vivo評価
野生型イネいもち病菌としてPyricularia oryzae Kita1株(NBRC30736株)を用いた。薬剤耐性型イネいもち病菌はP. oryzae R2-1あるいはP. oryzae KR5-1を用いた。R2-1株は佐賀県で単離されたカルプロパミド耐性菌であり、SDH1遺伝子にGTGからATGへの変異(V75M変異)を持っていることを確認している(前記文献X参照)。KR5-1株はKita1株のSDH1遺伝子を薬剤耐性型(V75M)のものに置換することにより作製した。
Example 3: In vivo evaluation of melanization inhibitory activity against rice blast fungus Pyricularia oryzae Kita1 strain (NBRC30736 strain) was used as the wild type rice blast fungus. P. oryzae R2-1 or P. oryzae KR5-1 was used as the drug-resistant rice blast fungus. The R2-1 strain is a carpropamide-resistant bacterium isolated in Saga Prefecture, and has been confirmed to have a mutation from GTG to ATG (V75M mutation) in the SDH1 gene (see Document X above). The KR5-1 strain was created by replacing the SDH1 gene of the Kita1 strain with a drug-resistant type (V75M).
(方法1)
24ウェルプレートの各ウェルに、500μLのポテトデキストロースブロス(PDB)+0.1%寒天培地(PDB(Difco製)に、寒天を0.1%添加したもの)を充填した。各ウェルに、イネいもち病菌を2%の濃度で添加して、その後、各ウェルに、前記式(I)の各化合物を100μMでそれぞれ添加し、25℃で7日間培養し、各試料培養液を得た。なお、対照用の培養液として、前記式(I)の化合物にかえてDMSOを添加した以外は同様に調製した対照用培養液(DMSO)、前記式(I)の化合物にかえて、カルプロパミドを同一の濃度で添加した以外は同様にして調製した対照用培養液(CPD)も、それぞれ準備した。
(Method 1)
Each well of a 24-well plate was filled with 500 μL of potato dextrose broth (PDB) + 0.1% agar medium (PDB (manufactured by Difco) with 0.1% agar added). Rice blast fungus was added to each well at a concentration of 2%, then each compound of the formula (I) was added to each well at 100 μM, cultured at 25°C for 7 days, and each sample culture solution I got it. As a control culture solution, a control culture solution (DMSO) was prepared in the same manner except that DMSO was added instead of the compound of formula (I), and carpropamide was added instead of the compound of formula (I). A control culture solution (CPD) was also prepared in the same manner except that the same concentration was added.
(方法2)
24ウェルプレートの各ウェルに、500μLのCYA培地(Czapek-Dox Broth(Difco製)に、酵母エキスを0.5%、ZnSO4を0.0001%、CuSO4を0.00005%添加したもの)を充填した。各ウェルに、イネいもち病菌を2%の濃度で添加して、その後、各ウェルに、前記式(I)の各化合物を100μMでそれぞれ添加し、25℃で7日間培養し、各試料培養液を得た。なお、対照用の培養液として、前記式(I)の化合物を添加しなかった以外は同様に調製した対照用培養液(-)、前記式(I)の化合物にかえてDMSOを添加した以外は同様に調製した対照用培養液(DMSO)、前記式(I)の化合物にかえて、カルプロパミドを同一の濃度で添加した以外は同様にして調製した対照用培養液(CPD)も、それぞれ準備した。
(Method 2)
In each well of a 24-well plate, 500 μL of CYA medium (Czapek-Dox Broth (manufactured by Difco) containing 0.5% yeast extract, 0.0001% ZnSO 4 and 0.00005% CuSO 4 ) was added to each well of a 24-well plate. filled with. Rice blast fungus was added to each well at a concentration of 2%, then each compound of the formula (I) was added to each well at 100 μM, cultured at 25°C for 7 days, and each sample culture solution I got it. In addition, as a control culture solution, a control culture solution (-) was prepared in the same manner except that the compound of formula (I) was not added, and a control culture solution (-) was prepared in the same manner except that DMSO was added instead of the compound of formula (I). A control culture solution (DMSO) prepared in the same manner as above, and a control culture solution (CPD) prepared in the same manner except that carpropamide was added at the same concentration in place of the compound of formula (I) above were also prepared. did.
(方法3)
24ウェルプレートの各ウェルに、500μLのPDB+Metal+0.1%寒天培地(PDB(Difco製)に、ZnSO4を0.0001%、CuSO4を0.00005%、寒天を0.1%添加したもの)を充填した。各ウェルに、イネいもち病菌を2%の濃度で添加して、その後、各ウェルに、前記式(I)の各化合物を30μMあるいは100μMでそれぞれ添加し、25℃で4日間培養し、各試料培養液を得た。なお、対照用の培養液として、前記式(I)の化合物にかえてDMSOを添加した以外は同様に調製した対照用培養液(DMSO)、前記式(I)の化合物にかえて、カルプロパミドを同一の濃度で添加した以外は同様にして調製した対照用培養液(CPD)も、それぞれ準備した。
(Method 3)
Into each well of a 24-well plate, 500 μL of PDB+Metal+0.1% agar medium (PDB (manufactured by Difco) with 0.0001% ZnSO4 , 0.00005% CuSO4 , and 0.1% agar added) filled with. Rice blast fungus was added to each well at a concentration of 2%, then each compound of formula (I) was added to each well at a concentration of 30 μM or 100 μM, and cultured at 25°C for 4 days. A culture solution was obtained. As a control culture solution, a control culture solution (DMSO) was prepared in the same manner except that DMSO was added instead of the compound of formula (I), and carpropamide was added instead of the compound of formula (I). A control culture solution (CPD) was also prepared in the same manner except that the same concentration was added.
イネいもち病のメラニン生合成経路が正常に機能していれば、培養によってメラニンが生成し、培養液が黒色化する。一方、メラニン生合成経路に関与するSDH1が阻害されると、シタロンの脱水が進行せず、結果として、メラニンが生成せず培養液の黒色化が起こらない。この場合、培養によってシタロンが蓄積する。各試料培養液及び各対照用培養液について、培養液の黒色化が起こるかどうかを観察したのちに、UPLC(Waters社製)を用いてシタロンの蓄積量を測定した。 If the melanin biosynthesis pathway in rice blast is functioning normally, melanin will be produced during cultivation and the culture solution will turn black. On the other hand, when SDH1, which is involved in the melanin biosynthesis pathway, is inhibited, the dehydration of Cytalon does not proceed, and as a result, melanin is not produced and the culture solution does not turn black. In this case, citalone accumulates during culture. For each sample culture solution and each control culture solution, it was observed whether the culture solution turned black, and then the accumulated amount of Citalone was measured using UPLC (manufactured by Waters).
培養するイネいもち病菌として、Kita1株を用いて、前記方法1~3のいずれかで評価した。いずれの方法でも、メラニン生合経路が正常に機能しているDMSOコントロール(及び対照用培養液(-))では、メラニンの生成により培養液が黒色化したことが目視にて確認された。一方、各試料培養液は、対照用培養液(CPD)と同様、黒色化が抑制されていることを目視にて確認した。更に、表2~4に示すように、黒色化が抑制されている培養液では、シタロンの蓄積が認められた。以上の結果から、前記式(I)の化合物が野生型のイネいもち病菌に対してメラニン産生を抑制すること、及びSDH1阻害活性を示すことがin vivoで実証された。 The Kita1 strain was used as the rice blast fungus to be cultured, and evaluation was performed using any of Methods 1 to 3 above. In either method, it was visually confirmed that in the DMSO control (and control culture solution (-)) in which the melanin biosynthesis pathway was functioning normally, the culture solution turned black due to the production of melanin. On the other hand, it was visually confirmed that blackening was suppressed in each sample culture solution, similar to the control culture solution (CPD). Furthermore, as shown in Tables 2 to 4, accumulation of citalone was observed in the culture solution in which blackening was suppressed. From the above results, it was demonstrated in vivo that the compound of formula (I) suppresses melanin production against wild-type rice blast fungus and exhibits SDH1 inhibitory activity.
培養するイネいもち病菌として薬剤耐性型イネいもち病菌(R2-1あるいはKR5-1)を用いて、方法1~3のいずれかで評価した。いずれの方法でも、メラニン生合経路が正常に機能しているDMSOコントロール(及び対照用培養液(-))では、メラニンの生成により培養液が黒色化したことが目視にて確認された。一方、各試料培養液は、対照用培養液(-)と比較して、黒色化が抑制されていることを目視にて確認した。更に、表3~4に示すように、黒色化が抑制されている培養液では、シタロンの蓄積が認められた。以上の結果から、前記式(I)の化合物が薬剤耐性型イネいもち病菌に対してメラニン産生を抑制すること、及びアミノ酸変異型SDH1に対する阻害活性を示すことがin vivoで実証された。 A drug-resistant rice blast fungus (R2-1 or KR5-1) was used as the rice blast fungus to be cultured, and evaluation was performed using any of Methods 1 to 3. In either method, it was visually confirmed that in the DMSO control (and control culture solution (-)) in which the melanin biosynthesis pathway was functioning normally, the culture solution turned black due to the production of melanin. On the other hand, it was visually confirmed that blackening of each sample culture solution was suppressed compared to the control culture solution (-). Furthermore, as shown in Tables 3 and 4, accumulation of citalone was observed in the culture solution in which blackening was suppressed. From the above results, it was demonstrated in vivo that the compound of formula (I) suppresses melanin production against drug-resistant rice blast fungi and exhibits inhibitory activity against amino acid mutant SDH1.
実施例4:イネに対する防除作用の評価
三葉期のイネいもち病菌Kita1株に感受性のイネ(日本晴れ)に対して、野生型イネいもち病菌(Kita1株)あるいは薬剤耐性型イネいもち病菌(KR5-1株)の胞子懸濁液20mL(単位体積mL当たり0.3×104になるように0.02%Tween20に懸濁)を、エアブラシを用いて噴霧摂取した。胞子懸濁液中に、前記式(I)の化合物(化合物26)あるいはCRPを10μM添加した。またコントロールとしてDMSOのみを添加したものを用いた。相対湿度100%、暗所、温度25℃の環境下で24時間感染させた後、それぞれ、人工気象器中で6日間、明期14時間25℃暗期10時間20℃の条件下で、いもち病の完全な病斑が生じるまで生育させた。栽培したそれぞれのイネについて、第2葉から第4葉に生じた病斑の数をカウントして、イネいもち病の発生を評価した。病原性の評価はそれぞれ14株のイネ(2ポット)を用いて行った。イネ一株あたりの病斑数を平均±標準偏差で示した。
Example 4: Evaluation of control effect on rice Rice that is susceptible to the rice blast fungus Kita1 strain at the three-leaf stage (Nipponbare) was treated with a wild-type rice blast fungus (Kita1 strain) or a drug-resistant rice blast fungus (KR5-1). 20 mL of a spore suspension (suspended in 0.02
図2に示す通り、イネに施用すると、カルプロパミドは野生型に対しては高い防除効果を示すものの、薬剤耐性菌に対してはほとんど活性を示さなかった。一方、化合物26は、野生型のみならず、薬剤耐性型のイネいもち病菌に対しても高い防除効果を示すことが実証された。 As shown in Figure 2, when applied to rice, carpropamide showed a high control effect against wild-type bacteria, but showed almost no activity against drug-resistant bacteria. On the other hand, it was demonstrated that Compound 26 exhibits a high control effect not only against wild type but also against drug-resistant rice blast fungi.
本明細書中で引用した全ての刊行物、特許及び特許出願をそのまま参考として本明細書中にとり入れるものとする。 All publications, patents, and patent applications cited herein are incorporated by reference in their entirety.
Claims (11)
(式中、A1~A4はそれぞれ、CH又はNを表し;Rは水素原子以外の置換基であり、nは0~4の整数であり、nが2以上のとき複数のRは互いに同一であっても異なっていてもよく、隣り合う炭素原子に結合したRは互いに結合して環を形成していてもよく;X1及びX2はそれぞれ、水素原子、C1-10-アルキル基、-CO-R5、-CO-OR5又は-SO2-R5であり;R5は置換又は非置換の炭素数1~10の炭化水素基、又は置換又は非置換のヘテロ環基である。)
で示される化合物から選ばれる少なくとも1種を含有するシタロン脱水酵素阻害剤。 The following formula (I):
(In the formula, A 1 to A 4 each represent CH or N; R is a substituent other than a hydrogen atom, n is an integer from 0 to 4, and when n is 2 or more, multiple R They may be the same or different, and R bonded to adjacent carbon atoms may be bonded to each other to form a ring; X 1 and X 2 are each a hydrogen atom, C 1-10 -alkyl group, -CO-R 5 , -CO-OR 5 or -SO 2 -R 5 ; R 5 is a substituted or unsubstituted hydrocarbon group having 1 to 10 carbon atoms, or a substituted or unsubstituted heterocyclic group )
A citalone dehydrase inhibitor containing at least one compound selected from the compounds shown below.
(式中、R1及びR2のいずれか一方は、置換又は非置換のC1-5-アルキル基、又は置換又は非置換のC1-5-アルコキシ基であり、R1及びR2の他方は、水素原子、置換又は非置換のC1-5-アルキル基、又は置換又は非置換のC1-5-アルコキシ基であり;R3及びR4は、それぞれ、水素原子、水酸基、ベンジルオキシ基、C2-6-アルカノイルオキシ基、置換又は非置換のC1-5-アルキル基、又は置換又は非置換のC1-5-アルコキシ基であり;X2は前記式(I)中のX2と同義である。)
である請求項1又は2に記載のシタロン脱水酵素阻害剤。 The above formula (I) is the following formula (II):
(In the formula, either one of R 1 and R 2 is a substituted or unsubstituted C 1-5 -alkyl group, or a substituted or unsubstituted C 1-5 -alkoxy group, and R 1 and R 2 are The other is a hydrogen atom, a substituted or unsubstituted C 1-5 -alkyl group, or a substituted or unsubstituted C 1-5 -alkoxy group; R 3 and R 4 are a hydrogen atom, a hydroxyl group, a benzyl group, respectively; is an oxy group, a C 2-6 -alkanoyloxy group, a substituted or unsubstituted C 1-5 -alkyl group, or a substituted or unsubstituted C 1-5 -alkoxy group; )
The citalone dehydrase inhibitor according to claim 1 or 2.
(式中、R1aは水素原子であり、R2aはメチル基、又は置換又は非置換のC1-3-アルコキシ基であり、R3aは水素原子であり、R4aはメチル基、水酸基、ベンジルオキシ基、C2-6-アルカノイルオキシ基、又は置換又は非置換のC1-3-アルコキシ基であり;Xaは-CO-又は-SO2-であり;R5aは置換又は非置換の炭素数1~10の炭化水素基、又は置換又は非置換のC1-3-アルコキシ基である。)
で示される化合物(但し、R1a及びR3aが水素原子であり、R2a及びR4aがメチル基であり、Xaが-CO-であり、R5aが非置換のイソプロピル基である化合物、R 1a 、R 3a 及びR 4a が水素原子であり、R 2a がメチル基であり、X a が-CO-であり、R 5a が非置換のtert-ブチル基である化合物、R 1a 及びR 3a が水素原子であり、R 2a 、R 4a 及びR 5a がメチル基であり、X a が-CO-である化合物、R 1a 及びR 3a が水素原子であり、R 2a 及びR 4a がメチル基であり、X a が-CO-であり、R 5a が3,4,5-トリメトキシフェニル基である化合物、及びR 1a 及びR 3a が水素原子であり、R 2a 及びR 4a がメチル基であり、X a が-CO-であり、R 5a が非置換のシクロプロピル基である化合物を除く)。 The following formula (IIa):
(In the formula, R 1a is a hydrogen atom, R 2a is a methyl group or a substituted or unsubstituted C 1-3 -alkoxy group, R 3a is a hydrogen atom, R 4a is a methyl group, a hydroxyl group, is a benzyloxy group, a C 2-6 -alkanoyloxy group, or a substituted or unsubstituted C 1-3 -alkoxy group; X a is -CO- or -SO 2 -; R 5a is substituted or unsubstituted is a hydrocarbon group having 1 to 10 carbon atoms, or a substituted or unsubstituted C 1-3 -alkoxy group.)
A compound represented by (provided that R 1a and R 3a are hydrogen atoms, R 2a and R 4a are methyl groups, X a is -CO-, and R 5a is an unsubstituted isopropyl group, Compounds in which R 1a , R 3a and R 4a are hydrogen atoms, R 2a is a methyl group, X a is -CO-, and R 5a is an unsubstituted tert-butyl group, R 1a and R 3a is a hydrogen atom, R 2a , R 4a and R 5a are methyl groups, and X a is -CO-, R 1a and R 3a are hydrogen atoms, and R 2a and R 4a are methyl groups. , a compound in which X a is -CO-, R 5a is a 3,4,5-trimethoxyphenyl group, and R 1a and R 3a are hydrogen atoms, and R 2a and R 4a are methyl groups. , excluding compounds in which X a is -CO- and R 5a is an unsubstituted cyclopropyl group ).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019048574 | 2019-03-15 | ||
JP2019048574 | 2019-03-15 | ||
PCT/JP2020/010142 WO2020189391A1 (en) | 2019-03-15 | 2020-03-10 | Rice blast control agent |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2020189391A1 JPWO2020189391A1 (en) | 2020-09-24 |
JP7437783B2 true JP7437783B2 (en) | 2024-02-26 |
Family
ID=72519065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021507225A Active JP7437783B2 (en) | 2019-03-15 | 2020-03-10 | Rice blast control agent |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP7437783B2 (en) |
WO (1) | WO2020189391A1 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000109404A (en) | 1998-10-01 | 2000-04-18 | Nippon Bayer Agrochem Co Ltd | Bacterial disease controller for plant |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58157705A (en) * | 1982-03-11 | 1983-09-19 | Rikagaku Kenkyusho | Agricultural and horticultural germicide |
-
2020
- 2020-03-10 JP JP2021507225A patent/JP7437783B2/en active Active
- 2020-03-10 WO PCT/JP2020/010142 patent/WO2020189391A1/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000109404A (en) | 1998-10-01 | 2000-04-18 | Nippon Bayer Agrochem Co Ltd | Bacterial disease controller for plant |
Non-Patent Citations (3)
Title |
---|
FRASINYUK, M. S. et al.,Synthesis and properties of 4-(3-amino-2-benzofuranyl)coumarins,Chemistry of Heterocyclic Compounds,2009年,45(10),1261-1269 |
REGISTRY(STN)[online],2006年8月25日[検索日:2020年5月25日]、CAS登録番号904501-07-01 |
REGISTRY(STN)[online],2007年4月9日[検索日:2020年5月25日]、CAS登録番号929490-29-9;2007年4月9日[検索日:2020年5月25日]、CA |
Also Published As
Publication number | Publication date |
---|---|
WO2020189391A1 (en) | 2020-09-24 |
JPWO2020189391A1 (en) | 2020-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5524200B2 (en) | Fungicides hydroxymoyl-tetrazole derivatives | |
KR100658378B1 (en) | Heterocyclic substituted isoxazolidines | |
KR20100125424A (en) | Fungicide hydroximoyl-tetrazole derivatives | |
JPS59231045A (en) | Cyclohexandione carboxylic acid derivative, manufacture and composition | |
WO2006081759A1 (en) | N-(2-substituted phenyl)-n-methoxycarbamates and their preparation as well as use | |
WO2007129454A1 (en) | 1,2-benzisothiazole derivative, and agricultural or horticultural plant disease-controlling agent | |
BR112021005127A2 (en) | methods of control or prevention of infestation of cereal plants by the phytopathogenic microorganism fusarium pseudograminearum | |
CH623727A5 (en) | ||
TW201208569A (en) | Novel heterocyclic alkanol derivatives | |
CA2896396A1 (en) | Plant growth regulating compounds | |
OA10106A (en) | (Hetero) -aryl-alkyl-cetoxim-o-ethers substituted insecticidal acaricides and nematocides process for their preparation agents containing them and their use as pest control agents | |
JP5513498B2 (en) | Fungicide hydroxymoyl-tetrazole derivative | |
JP7437783B2 (en) | Rice blast control agent | |
KR20100125423A (en) | Fungicide hydroximoyl-tetrazole derivatives | |
DE1670709A1 (en) | Pesticides | |
KR900006709B1 (en) | Process for the preparation of sulf enylated acylhydrazones | |
CN109553615B (en) | Pyrimidine salt compound and application thereof | |
DK179669B1 (en) | Succinimide compound | |
UA120701C2 (en) | N-cycloalkyl-n-{[2-(1-substitutedcycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives | |
JP2016511263A (en) | Bactericidal 3- {heterocyclyl [(heterocyclylmethoxy) imino] methyl} -oxadiazolone derivatives | |
JPH09176170A (en) | Microbicide | |
US9743665B2 (en) | Fungicidal 3-{phenyl[heterocyclylmethoxy)imino]methyl}-oxadiazolone derivatives | |
JPH03169872A (en) | Composition for protecting plant from disease | |
JP2584807B2 (en) | Maleimide derivative, process for producing the same, and agricultural / horticultural fungicide containing the same as an active ingredient | |
JP3090995B2 (en) | 3,4-trans-4-ethyl-3- (substituted phenyl) -1- (3-isopropylphenyl) -2-pyrrolidinone derivative, |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230215 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231212 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240118 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240130 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240205 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7437783 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |